AAArzu Etem Akağaç

Arzu Etem Akağaç

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Arzu Etem Akağaç has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Measurement uncertainty, reference change value, and total error of total and free prostate specific antigen tests

    by Arzu Etem, Hatice Bozkurt Yavuz

    Objectives: The dispersion of measurement results is defined as the measurement uncertainty (MU), and the reference change value (RCV) indicates whether the difference between the current result and previous results is significant. The purpose of this study is to evaluate whether the analytical performance of total PSA (tPSA) and free PSA (fPSA) measurements conforms to international quality standards by determining analytical coefficient of variation (CVA), Bias, MU, and RCV values and comparing them with European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)’s allowable limits. Methods: The study includes Internal Quality Control (IQC) and External Quality Assurance (EQA) results for the period from August 2021 to February 2022 of tPSA and fPSA. While the long-term CV was obtained from IQC for MU and RCV values, Total Error (TE) values were calculated with the monthly IQC CV and EQA bias. MU Extended values (MU%) are calculated according to ISO/TS 20914. Results: The CVA of tPSA and fPSA was 3.44 % and 7.26 %, respectively. tPSA’s RCV and MU were found to be 17.78 and 9.74, and fPSA’s RCV and MU were found to be 23.7 and 15.23, respectively. Conclusions: Our results indicate that tPSA demonstrates better analytical performance than fPSA due to its lower CV and bias values. We found that the RCV of a test, such as tPSA and fPSA, which play a key role in post-operative follow-up, must be calculated and shared with the surgeon. In addition, since the cut-off value decides whether or not to request a reflective fPSA, MU should also be calculated and reported.

  • Open Access

    ANO1 (TMEM16A) Genetic Variants, Promoter Methylation, and Chloride Dysregulation in Pulmonary Hypertension

    by İrfan Yaman, Hasan Korkmaz, Arzu Etem Akağaç, Tuğçe Kaymaz, Rauf Önder, Ebru Etem Önalan

    Background: Pulmonary arterial hypertension (PAH) is a rare and progressive disorder characterized by increased pulmonary vascular resistance and vascular remodeling. Genetic polymorphisms, epigenetic modifications, and ion channel dysregulation are increasingly recognized as key contributors to disease pathogenesis. Anoctamin-1 (ANO1/TMEM16A), a calcium-activated chloride channel, plays a critical role in vascular tone regulation. Objective: This study aimed to investigate the association between ANO1 gene polymorphisms (rs7127129 and rs2509153), promoter methylation status, and serum chloride levels in patients with idiopathic pulmonary arterial hypertension (IPAH), congenital heart disease (CHD), and chronic thromboembolic pulmonary hypertension (CTEPH). Methods: A total of 106 IPAH patients, 40 CHD patients, and 30 CTEPH patients, together with 125 healthy controls, were included. The control group had a comparable age distribution, with a balanced sex ratio, whereas females predominated in all three PH groups. Genotyping was performed using TaqMan-based real-time PCR. Promoter methylation was analyzed using bisulfite conversion followed by quantitative real-time PCR. Serum chloride levels were measured using an ion-selective electrode method. Results: No significant association was observed between rs7127129 and rs2509153 polymorphisms and IPAH or CTEPH (p > 0.05). However, rs7127129 showed a significant association with CHD (p < 0.05). After excluding hypertensive patients, both polymorphisms remained significantly associated with CHD. Serum chloride levels differed significantly among groups (p < 0.001), with higher levels observed particularly in the CTEPH and CHD groups compared to controls, while IPAH patients exhibited intermediate but still elevated levels relative to controls. In contrast, promoter methylation levels were significantly lower in all patient groups compared to controls. An inverse relationship between chloride levels and methylation status was observed. Conclusions: ANO1 polymorphisms are not major determinants of IPAH or CTEPH but may contribute to CHD susceptibility. Increased serum chloride levels, together with decreased promoter methylation, suggest a potential mechanistic link between ion channel dysregulation and epigenetic alterations in pulmonary hypertension. Further large-scale and functional studies are warranted.

  • Open Access

    Polikistik over sendromu oluşturulmuş sıçanlarda irisinin metabolik yolaklar ve bu yolaklarda görevli gen ifadeleri üzerine etkileri

    by İlAy Buran Kavuran, Ebru Önalan, Ebru Çelik Kavak, Emine Kacar, Tuncay Kuloğlu, Arzu Etem Akağaç, Ahmet Tektemur

    Amaç: Pkos sıklıkla obezitenin eşlik ettiği endokrin ve metabolik bir bozukluktur. Mevcut çalışmamızda obez pkos sıçan modelinde egzersizin etkilerinin biyokimyasal ve moleküler düzeyde araştırılması amaçlanmıştır. Yöntem: 21 günlük, 24 Wistar albino dişi sıçan Kontrol, Pkos, Pkos+Egzersiz, Egzersiz olmak üzere 4 gruba ayrıldı (n=6). Obez pkos modeli 50 günlük deney süresince yüksek yağlı diyetle beslenme ve deneyin 1.-28. günler arasında subkutan 10mg/kg/gün Testosteron Propiyonat uygulamasıyla oluşturuldu. Egzersiz grupları 29.-50. günler arasında günlük 1 saat silindir tankta yüzdürüldü. Sıçanlara günlük vajinal simear yapılarak menstrueal siklus takibi yapıldı. Serumda LH, FSH ve İrisin seviyeleri Elisa ile ölçüldü. Over, beyaz yağ (Bat), kahverengi yağ ve kas dokularında UCP2, UCP3, FNDC5 genlerinin ve over dokusunda apoptoz ve otofaji ile ilişkili genlerin ifadeleri qRT-PCR ile belirlendi. Bulgular: Kas ve Bat dokusunda kontrole göre Pkos ve Pkos+egzersiz gruplarında UCP2 (p=0.01 ve p=0.01) ve UCP3 (p=0.004 ve p=0.04) ifadesi anlamlı olarak artarken Egzersiz grubunda Bat dokusunda UCP2 azalmıştır (p=0.01 ve p=0.01). Kasda FNDC5 ifadesi Pkos (p=0.01), Pkos+Egzersiz (p=0.0007) ve Egzersiz (p=0.02) gruplarında anlamlı olarak azalırken, bat’da artmıştır. Serum irisin düzeylerinin Pkos ve Pkos+Egzersiz gruplarında anlamlı olarak daha düşük olduğu (p=0.001), Overde ise apoptozis ve otofaji ilişkili gen ifadelerinin Pkos ve Pkos+egzersiz gruplarında anlamlı arttığı gözlenmiştir (p

  • Open Access

    Hyperhomocysteinemia Transcriptionally Regulates Expression of a Set of Ion Channels in Brain and Heart Tissues in Mice

    by Ebru Önalan, İlAy Buran Kavuran, Ahmet Tektemur, Esin Öz, Seda Özaydın, Arzu Etem Akağaç, Ramazan Bal

    The alterations of ion channel gene expressions in brain and heart tissues in HHcy have not been previously reported. We investigated the mRNA expression levels in brain and heart tissues of the HHcy mice compared to the control mice to characterize distinct expression of 36 ion channels. C57BL/6 J. mice were divided into two groups of 15 animals each: (1) control group and (2) HHcy group. The HHcy was induced by methionine administiration. The mRNA levels of ion channels were analyzed using qRT-PCR. TUNEL staining and MDA assay were used for verification of the negative side effects of HHcy in heart and brain tissues. RT-PCR revealed the upregulation of Hcn4, Trpc3, Trpm2 and the downregulation of Abbc8, Cacna1b, Cacna1c, Cacna1e, Cacna1h, Hcn1, Kcnc3, Kcnh7, Kcnj8, Trpc4, Trpc5, Trpc6, Trpm3, Trpm4, Trpv4, Trpv6 in brain tissues of the HHcy group compared to the control. The upregulation of ion channel expressions in heart tissues were not detected, but we found only the downregulation of Accn1, Accn2, Accn3, Hcn1, Kcnc4 and Trpv6 ion channels. Apoptozis and MDA level were significantly increased in brain and heart tissues of the HHcy group compared to the control. Brain tissues compared to heart tissues exhibit a very considerable and diverse ion channel gene expression pattern in mice with HHcy than control. Clarifying the roles of ion channels in HHcy could shed light on the development of novel therapeutic strategies and ultimately improve HHcy side effects.


  • Essential Characteristics of Health Information Systems

    by Ecenur Aydemir, Arzu Etem, M. Fevzi Esen

    In the evolving healthcare landscape, the adoption of Health Information System (HIS) is crucial due to the surge in chronic diseases globally. This chapter examines the key components of clinical HIS, emphasizing their role in enhancing healthcare delivery and patient care. Despite the potential benefits, the implementation of HIS faces challenges such as high costs, integration complexities, and data security concerns. However, the advantages of improved patient care, enhanced efficiency, and data-driven decisions highlight the indispensability of HIS in modern healthcare. Furthermore, this chapter presents a bibliometric analysis to assess the current research landscape on HIS. The analysis reveals trends, gaps, and the impact of HIS on healthcare delivery and patient outcomes. By providing a comprehensive overview of the components, benefits, challenges, and research landscape of clinical HIS, this chapter emphasizes the crucial role of these systems in transforming healthcare and improving patient care. Request access from your librarian to read this chapter's full text.

  • Kronik Böbrek Hastalığına Bağlı Olan Serum hCG Yüksekliği

    by Arzu Etem Akağaç, Soycan Mızrak, Tolga Mızrak

    Amaç: Son zamanlarda yayınlanan bazı makaleler yanlış pozitif human koryonik gonadotropin (hCG) sonuçlarının kaynağını araştırmıştır. Bu olgu, kronik böbrek hastalığı (KBH) olan genç bir kadın hastada hafif yüksek gerçek pozitif bir hCG sonucunu göstermektedir. Gereç ve Yöntem: Hastanın serum hCG değeri 4 immunoassay sistemi ile ölçüldü. Daha sonraki aşamada dilüsyon ve PEG 6000 ile çöktürme gerçekleştirildi. Bulgular: 4 immunoassay yöntemi ilede hCG sonuçları bir miktar yüksek bulundu. Immulite ile geri kazanım oranı dilüsyon sonucu için 0,98, PEG sonucu için 0,54 olarak hesaplandı. Dilüsyon ve PEG 6000 ile çöktürme çalışmaları, heterofil antikorların varlığını desteklemedi. Sonuç: Sonuçların hepsi birlikte değerlendirildiğinde beklenmeyen pozitif hCG sonucunun KBH’na sekonder olduğu gösterildi. Bizim vakamız gibi KBH hastalarında HCG yüksekliği olabileceği göz önünde bulundurulmalıdır.

  • Open Access

    Fibrin clot interference in a human chorionic gonadotrophin assay causing a false Down syndrome screening result

    by Arzu Etem Akagac, Hatice Bozkurt Yavuz

    Serum samples are generally used for the measurement of human chorionic gonadotrophin (hCG) to calculate second-trimester maternal screening results. Lower hCG concentrations correlate with a lower calculated risk of Down syndrome (DS). Hence, erroneously low hCG results due to fibrin clot may lead to misinterpretation. We present a 23-year-old woman with a pregnancy of 17+3 weeks. Blood was taken into the Becton-Dickinson (BD) vacutainer SST-II Advance tube (Ref: 367955). The hCG test was performed on Immulite 2000 XPi analyser (Siemens Healthcare Diagnostics Inc, Tarrytown, USA) with original reagents. The results of the same sample were found as 2566 U/L, 18,153 U/L, and 7748 U/L. Three consecutive results after removal of the small fibrin clot and recentrifugation were 18,878, 20,255, and 22,339 U/L. The risk of DS and MoM for the concentration of 2556 U/L hCG was < 1/10,000 and 0.14, respectively. For a hCG concentration of 20,255 U/L, these values were 1/5632 and 1.13, respectively. Laboratory professionals and technicians should be aware that erroneously low hCG results can be measured with the Immulite 2000 XPi due to interference from small fibrin clots. Falsely underestimated hCG values reduce the MoM values and thus the calculated risk of DS.


  • Open Access

    Total Oxidant and Total Antioxidant Capacity in Children with Vitiligo: A Case-Control Study

    by Burçin Erdem Kinaş, Arzu Etem Akağaç, Filiz Cebeci̇ Kahraman, Betül Sezgi̇n, Ahmet Rıza Uras

    Amaç: Vitiligo; etiyolojisi tam olarak açıklanamayan, melanosit destrüksiyonuyla karakterize, klinik olarak iyi sınırlanmış depigmente lezyonlarla kendini gösteren herediter, kazanılmış bir hastalık olarak bilinmektedir. Bu çalışmada, vitiligolu çocuklarda total oksidan kapasite [total oxidant capacity (TOS)], total antioksidan kapasite [total antioxidant capacity (TAS)] düzeyleri ve oksidatif stres indeksinin (OSI) hesaplanması amaçlandı. Gereç ve Yöntemler: Çalışma grubunda; TOS ve TAS düzeyleri, kolorimetrik yöntem ile Rel Assay kitleri kullanılarak çalışıldı. OSI; (TOS, umol H202 equivalent/L/TAS, umol Trolox equivalent/L)x100 formülü ile hesaplandı. Çalışma grubu 30 (13 erkek, 17 kız) vitiligolu hasta ve 30 (16 erkek, 14 kız) sağlıklı kontrol grubundan oluşmaktaydı (p>0,05). Bulgular: Vitiligolu çocukların yaş ortalaması 9,17±4,87 iken, vitiligosu olmayan sağlıklı çocukların yaş ortalaması 9,27± 3,88 idi. Vitiligolu hastalarda ve sağlıklı kontrol grubunda TAS düzeyleri sırasıyla 0,996±0,124 ve 1,032±0,097 umol Trolox equivalent/L olarak bulundu (p>0,05). TOS düzeyleri ise vitiligolu hastalarda 3,98±3,14 ve sağlıklı kontrol grubunda 3,61±1,43 umol H202 equivalent/L olarak bulundu (p>0,05). OSI değeri ise vitiligolu hastalarda 0,399±0,30 ve kontrol grubunda 0,351± 0,14 olarak hesaplandı (p>0,05). Sonuç: Sonuç olarak vitiligolu hasta grubu ile kontrol grubunda TAS, TOS ve OSI değerleri arasında anlamlı bir fark bulunmadı. Çalışmamızda, nonenzimatik serum TAS ölçüldü. Buna göre TAS düzeyi düşük, TOS ve OSI düzeyleri yüksek olmasına rağmen bu değerler istatistiksel olarak anlamlı değildi. Sonuç olarak vitiligolu çocuk hastalarda, organizmanın oksidatif strese girmediği düşünülebilir ve bu sonuçlar daha ileri çalışmalarla desteklenebilir.

  • Open Access

    Comparison of enzyme-linked fluorescent assay and electrochemiluminescence immune assay in procalcitonin measurement

    by Burçin Erdem Kinas, Arzu Etem Akagac, Aybala Erek Toprak, Sule Batcık, Ahmet Rıza Uras

    Background: Procalcitonin (PCT) measurement is required for intensive care patients with systemic inflammation symptoms, early diagnosis of possible infections, and evaluation of sepsis severity and prognosis. Objectives: We aimed to determine the analytical performance of PCT measurement in a Roche Modular E170 (ECLIA) analyzer and compare the performance with VIDAS (BRAHMS/ELFA) analyzer findings. Material and methods: Within-day and between-day precision value, linearity was determined, and two methods were compared with regression and Bland–Altman analysis. Results: Both ECLIA and ELFA assays indicated excellent precision, where within-day precision varied between 1.18% and 3.97% CV, and between-day precision varied between 1.77% and 3.93% CV. The ECLIA method was linear up to 62.15 ng/mL. The arithmetic mean was 6.02 ng/mL with the ECLIA method and 8.02 ng/mL with the ELFA method. The correlation coefficient was r=0.996 and p=0.001. The correlation was linear between the two methods. Regression equation was found y=0.78x − 0.23. The Bland–Altman figure was revealed the difference between the methods was specifically in lower concentrations (<0.15 ng/mL). Conclusions: Both methods show good precision and correlation. It was determined that the difference between methods was significant, especially at <0.15 ng/mL concentration.


  • Cardiac panel evaluation of usak state hospital stat laboratory

    by Arzu Akağaç Etem, Abdurrahman Yılmaz

    Aim In this study, we aimed to determine clinical usefulness and advantages of ordering tests that include total creatine kinase (CK), creatine kinase myocar- dial band (CK-MB, enzymatic), troponin I, myoglobin, and CK-MB (mass) in stat laboratory of our hospital with an assessment according to patients diagnoses in Usak region. Methods Four hundred thirty-eight patients presenting to Usak State Hospital Stat Laboratory between March 2010 and April 2010 were included in this study. CK, CK-MB (enzymatic), troponin I, myoglobin, and CK-MB (mass) levels, diagnosis, and hospitalization were evaluated. Results Among the total of 107 patients, 41 (9,3%) were hospitalized to coronary intensive care unit, 13 (2,9%) to cardiology service, 13 (2,9%) to chest disease service, 10 (2,2%) to internal medicine service, 10 (2,2%) to neurology service, 5 (1,1%) to chest disease intensive care unit, and 15 (3,4%) to other services (24,4%). The preliminary diagnosis and second diagnosis after hospitalization were found same (89.9%). Seventy-eight (17,8%) patients had troponin level over the upper reference limit of 0,06ng/mL (mean ± SD;5,130 ± 11,682 (0,06-50) ng/mL); 108 (24,6%) patients had myoglobin level over the upper reference limit of 110ng/mL. Sixteen (%3,65) patients were diagnosed with AMI. Conclusion In our study, we found that nearly half of the patients ordering cardiac marker tests in the stat clinical biochemistry laboratory were hospitalized associated with cardiovascular system services. The preliminary diagnosis and second diagnosis after hospitalization were found the same (89.9 %) and this value was evaluated as good in terms of clinical practice. Early diagnosis of acute coronary syndrome (ACS), hospitalization to an appropriate service, and treatment or timely invasive procedures are provided to shorten hospital stay and improve disease prognosis.